Panacea Biotec receives LoA from CMSS
The new test offers a minimally invasive blood-based approach to tracking neurological damage, measuring neurofilament light chain
No adverse events reported; recall involves 5 mg 500-count bottles in the US market
The study is a global, randomized, double-blind, placebo-controlled trial testing GLM101 for phosphomannomutase 2 congenital disorder of glycosylation
New digital health companion uses friendly, jargon-free communication to help users better understand reports
Landmark procedure restores 32-year-old CKD patient’s health, highlighting how public insurance is widening access to advanced renal care
Divestment marks Redcliffe’s strategic pivot toward preventive and advanced diagnostics; Crysta IVF to continue under existing leadership
India’s first prospective study finds molecular testing improved diagnostic clarity in 50% of complex sarcoma cases
MoU to deploy Qure.ai’s chest X-ray solution across 20 government facilities aims to improve early detection in urban and rural populations
Subscribe To Our Newsletter & Stay Updated